Delcath Systems, Inc.
NASDAQ:DCTHMedical - Devices
-$0.23 today
- Market cap
- $685.32M
- Beta
- 0.52
- P/E (TTM)
- 751.4
- EPS (TTM)
- $0.02
Volume 0.59M
Average 0.42M
DCTH Sales of Investments
Cash received from selling or redeeming investments.
Delcath Systems, Inc.NASDAQ: DCTH
Sales of Investments · Q1 FY2026 · quarter ended Mar 2026
Sales of investments growth accelerates
Q1 FY2026 sales of investments of $15.81M rose 213.0% year over year, ahead of the +87.6% change in trailing-twelve-month sales of investments. Sequentially, it fell 50.2% from the prior quarter.
Context
- Sales of investments amounted to 80.0% of revenue in FY2025, down 59.9 pp from a year earlier.
- Sales of investments increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +213.0% holds above the trailing-twelve-month pace of +87.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 68.17M USD
- Year-over-year change
- +31.0%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 68.17M | +31.0% |
| FY2024 | 2024-12-31 | 52.03M | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Sales of Investments vs competitors
How DCTH compares with its peers on the latest reported figures
- DCTH's LTM Mar 2026 sales of investments of $78.93M is the 3rd largest of the 4 companies compared; the peer median is $199.89M.
- Its year-over-year change of +87.6% is the lowest of 3, against a peer median of +99.1%.
- Sales of investments amounts to 87.3% of revenue for DCTH, versus a peer median of 189.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $1.28B | +99.2% | +2.9% | 189.1% | |
| LTM Mar 2026 | $199.89M | +99.0% | — | 32344.2% | |
| LTM Mar 2026 | $78.93M | +87.6% | — | 87.3% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding DCTH) | $199.89M | +99.1% | +2.9% | 189.1% | |
Competitors are the stored peer set for DCTH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (25.65M) | (36.51M) | (47.68M) | (26.39M) | 2.7M |
| Depreciation & Amortization | 146K | 132K | 128K | 229K | 349K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 7.83M | 7.94M | 8.15M | 9.77M | 24.23M |
| Change in Working Capital | (5.76M) | 2.11M | (906K) | (15.52M) | (3.07M) |
| Accounts Receivables | 13K | (322K) | 125K | (10.65M) | (854K) |
| Inventory | (557K) | (587K) | (1.32M) | (3.61M) | (3.32M) |
| Accounts Payables | (1.14M) | 1.8M | (199K) | 479K | 4.77M |
| Other Working Capital | (4.08M) | 1.23M | 492K | (1.74M) | (3.66M) |
| Other Non-Cash Items | 831K | 1.37M | 9.05M | 13.23M | (1.7M) |
| Operating Cash Flow | (22.6M) | (24.95M) | (31.25M) | (18.68M) | 22.52M |
| Capital Expenditures | (143K) | (209K) | (58K) | (559K) | (1.55M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | (19.65M) | (52.45M) | (93.22M) |
| Sales of Investments | 0 | 0 | 0 | 52.03M | 68.17M |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (143K) | (209K) | (19.71M) | (981K) | (26.59M) |
| Debt Repayment | 14.44M | (714K) | (6.31M) | (10.61M) | 0 |
| Common Stock Issued | 3.92M | 10.86M | 23.08M | 7.02M | 21.05M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | (6M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 2.46M | 0 | 35.01M | 43M | 0 |
| Financing Cash Flow | 20.82M | 10.14M | 51.78M | 39.41M | 15.05M |
| Effect of Forex Changes | 122K | (115K) | 56K | (32K) | 68K |
| Net Change in Cash | (1.8M) | (15.13M) | 874K | 19.72M | 11.04M |
| Free Cash Flow | (22.75M) | (25.16M) | (31.31M) | (19.24M) | 20.97M |
Delcath Systems, Inc.
NASDAQ:DCTH
Intrinsic Alpha fair value
Locked
Current Price
$19.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.